Takayuki Yoshino, MD

Articles by Takayuki Yoshino, MD

The COLOMATE Platform: An Indispensable Initiative Promoting True Precision Oncology Prioritized for Patients With Cancer—From “MAYBE” to “MUST BE”

ByTakayuki Yoshino, MD

September 22nd 2021

Takayuki Yoshino, MD, PhD provides perspective on key issues surrounding therapy selection in gastrointestinal cancers.

Clinical Trials in Progress: GOZILA

ByYoshiaki Nakamura, MD,Takayuki Yoshino, MD

July 25th 2021

Nationwide Circulating-Tumor DNA–Guided Basket and Umbrella Clinical Trials for Patients With Advanced Solid Tumors (GOZILA; UMIN000029315)

Comparing GOZILA and COLOMATE: Ongoing Umbrella/Basket Trials Examining Genetic Testing in Gastrointestinal Malignancies

ByHideaki Bando, MD,Yoshiaki Nakamura, MD,Daisuke Kotani, MD,Takayuki Yoshino, MD

July 17th 2021

Circulating tumor DNA (ctDNA)-based next- generation sequencing (NGS) assays have advantages over classic tissue-based analyses because of their low invasiveness and availability of repeated sampling. The existence of various companion trials for common alterations that can be potential therapy targets on the 2 platforms can lead to future international collaboration.